AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025
AK Medical Holdings reported a 5.6% rise in revenue to RMB694.2 million for H1 2025, compared to RMB657.1 million in H1 2024. Gross profit increased by 3.0% to RMB410.3 million, while profit for the period rose 15.3% to RMB160.6 million. The gross margin decreased to 59.1% from 60.6% year-on-year. Cost of sales rose by 9.8% to RMB283.9 million, and other income surged to RMB18.3 million from RMB2.9 million in the previous year. Selling and distribution expenses increased by 3.8% to RMB117.3 million.
For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
